Dear Colleagues and Friends,
We are delighted to announce a new webinar series in collaboration with immunopaedia and Frontiers!
Encouraged by very successful series of 20 webinars that focusing on COVID-19 research developments that attracted more than 8,800 scientists from 86 countries, the webinars in 2021 will broaden the scope to cover a various hot topics in immunological research such as Autoimmunity, Infectious diseases and Allergology.
We look forward to seeing you at our next live webinar!
Immunoregulation and the tumor microenvironment
Date: February 8, 2020
Time: 15:00 (CET)
Although PD-1 blockade has transformed cancer treatment, a deeper understanding of tumor immunobiology and inhibitory mechanisms are needed to take immunotherapy to the next level. This webinar will cover topics including the cell types that express key B7 family members and their receptors including PD-L1, B7-H3, B7-H4 and PD-1 and discuss whether these findings align with the traditional views for what is going on in the tumor microenvironment. In addition, it will cover unexpected immunoregulatory mechanisms that we have found focussing on innate lymphoid cells.
Dr. Pamela Ohashi received her Ph.D from the University of Toronto with Dr. Tak Mak, and did her post-doctoral training at the University of Zurich with the Nobel Laureate Dr. Zinkernagel, and Dr. Hans Hengartner. She is a Senior Scientist and Director of the Tumor Immunotherapy Program at the Princess Margaret Cancer Centre, and a Professor in the Department of Immunology at the University of Toronto. Her interests include understanding CD8+ T cell biology and mechanisms that regulate anti-tumor immunity.